Group One Trading’s Bicara Therapeutics BCAX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAX
SL
Group One Trading's BCAX Position: Q3 2026 in Review
Group One Trading opened a new position in Bicara Therapeutics (BCAX) in Q3 2026: 4,090 shares worth $76.1K. The stake represents ﹤0.01% of the portfolio and ranks #4937 among its holdings. This is a return to the name: Group One Trading previously reported a position in BCAX as recently as Q1 2026.
Group One Trading first reported a position in BCAX in Q4 2025 and has held it in 3 quarters since. The position peaked at $285K in Q4 2025. 169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.
- Group One Trading held 4,090 shares of Bicara Therapeutics worth $76.1K as of Q3 2026.
- Bicara Therapeutics was a new Group One Trading position in Q3 2026.
- Bicara Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #4937 holding.
- Group One Trading first reported a position in Bicara Therapeutics in Q4 2025 and has held it in 3 quarters since.
- Group One Trading's Bicara Therapeutics position peaked at $285K in Q4 2025.
- 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.